The highly anticipated novel Retatrutide 20mg pen is now becoming available in the UK. As of now, access is limited and primarily via specialist healthcare providers participating in clinical programs. While a full, broad commercial rollout date remains tentative, sources suggest that individuals could be able to access the drug via private channel